Residency · ATLANTA, GA
Sponsored by Emory University School of Medicine
[89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial.
The Lancet. Oncology · 2024 · 122 citations · David Schuster
Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities.
AJNR. American journal of neuroradiology · 2025 · 63 citations · Marc Benayoun
AI pitfalls and what not to do: mitigating bias in AI.
The British journal of radiology · 2023 · 143 citations · Kaesha Thomas
Prospective Evaluation of Artificial Intelligence Triage of Intracranial Hemorrhage on Noncontrast Head CT Examinations.
AJR. American journal of roentgenology · 2024 · 48 citations · Gopi Sirineni
Applications of artificial intelligence in orthopaedic surgery.
Frontiers in medical technology · 2022 · 75 citations · Harun Sugito
Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022 · 124 citations · Bital Savir-Baruch
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.
Lancet (London, England) · 2021 · 160 citations · Raghuveer Halkar, David Schuster
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia.
Cancer discovery · 2024 · 74 citations · Shahein Tajmir